Peter Bains

Peter Bains is an experienced executive in the biopharmaceutical industry, currently serving as Chief Business Officer at MINA THERAPEUTICS LIMITED since January 2018. Prior to this role, Peter was the Chief Executive Officer and Board Director at Sosei Heptares from 2011 to 2018, and held similar positions at Syngene International Limited from March 2010 to March 2016. Peter's career at GlaxoSmithKline spanned over two decades, where duties included Senior Vice President of Commercial Development International from 1986 to 2009. Peter Bains holds a Bachelor of Science degree in Physiology from The University of Sheffield.